Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

by | Apr 1, 2026 | Clinical Trials | 0 comments

​ Conditions: Solid Tumors

Interventions: Drug: RT01-89Zr

Sponsors: Nanolattix Biotechnology Co., Ltd.

Recruiting Conditions: Solid Tumors
Interventions: Drug: RT01-89Zr
Sponsors: Nanolattix Biotechnology Co., Ltd.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *